1. P03.15 Site-specific immune evasion and substantial heterogeneity within entities provide evidence for personalized immunotherapy. (1st October 2020) Authors: Thelen, M; Wennhold, K; Lehmann, J; Staib, E; Garcia Marquez, MA; Lohneis, P; Lechner, A; Wagener-Ryczek, S; Plum, PS; Pfister, D; Dörr, F; Beutner, D; Thangarajah, F; Ratiu, D; Malter, W; Merkelbach-Bruse, S; Bruns, CJ; Quaas, A; von Bergwelt-Baildon, MS; Schlößer, HA Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 2 Page Start: A28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗